Literature DB >> 20397943

Epidemiology and challenges to the elimination of global tuberculosis.

Mandeep S Jassal1, William R Bishai.   

Abstract

Recent epidemiological indicators of tuberculosis (TB) indicate that the Millennium Development Goal of TB elimination by 2050 will not be achieved. The majority of incident cases are occurring in population-dense regions of Africa and Asia where TB is endemic. The persistence of TB in the setting of poor existing health infrastructure has led to an increase in drug-resistant cases, exacerbated by the strong association with human immunodeficiency virus coinfection. Spreading drug resistance threatens to undo decades of progress in controlling the disease. Several significant gaps can be identified in various aspects of national- and international-directed TB-control efforts. Various governing bodies and international organizations need to address the immediate challenges. This article highlights some of the major policies that lawmakers and funding institutions should consider. Existing economic and social obstacles must be overcome if TB elimination is to be a reachable goal.

Entities:  

Mesh:

Year:  2010        PMID: 20397943      PMCID: PMC4575217          DOI: 10.1086/651486

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  67 in total

Review 1.  Programmes and principles in treatment of multidrug-resistant tuberculosis.

Authors:  Joia S Mukherjee; Michael L Rich; Adrienne R Socci; J Keith Joseph; Felix Alcántara Virú; Sonya S Shin; Jennifer J Furin; Mercedes C Becerra; Donna J Barry; Jim Yong Kim; Jaime Bayona; Paul Farmer; Mary C Smith Fawzi; Kwonjune J Seung
Journal:  Lancet       Date:  2004-02-07       Impact factor: 79.321

2.  The new Stop TB Strategy and the Global Plan to Stop TB, 2006-2015.

Authors:  Mario C Raviglione
Journal:  Bull World Health Organ       Date:  2007-05       Impact factor: 9.408

3.  Reply to 'Addressing smoking cessation in tuberculosis control'.

Authors:  Annemieke Brands; Salah-Eddine Ottmani; Knut Lönnroth; Léopold J Blanc; Khalilur Rahman; Douglas W Bettchera; Mario Raviglione
Journal:  Bull World Health Organ       Date:  2007-08       Impact factor: 9.408

Review 4.  Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration.

Authors:  Alasdair Reid; Fabio Scano; Haileyesus Getahun; Brian Williams; Christopher Dye; Paul Nunn; Kevin M De Cock; Catherine Hankins; Bess Miller; Kenneth G Castro; Mario C Raviglione
Journal:  Lancet Infect Dis       Date:  2006-08       Impact factor: 25.071

Review 5.  Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes.

Authors:  Haileyesus Getahun; Mark Harrington; Rick O'Brien; Paul Nunn
Journal:  Lancet       Date:  2007-06-16       Impact factor: 79.321

Review 6.  Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis.

Authors:  Janina Morrison; Madhukar Pai; Philip C Hopewell
Journal:  Lancet Infect Dis       Date:  2008-04-29       Impact factor: 25.071

7.  Association between sputum smear status and local immune responses at the site of disease in HIV-infected patients with pulmonary tuberculosis.

Authors:  Henry C Mwandumba; S Bertel Squire; Sarah A White; Mukanthu H Nyirenda; Samuel D Kampondeni; Elizabeth R Rhoades; Eduard E Zijlstra; Malcolm E Molyneux; David G Russell
Journal:  Tuberculosis (Edinb)       Date:  2007-10-03       Impact factor: 3.131

Review 8.  Tobacco and tuberculosis: a qualitative systematic review and meta-analysis.

Authors:  K Slama; C-Y Chiang; D A Enarson; K Hassmiller; A Fanning; P Gupta; C Ray
Journal:  Int J Tuberc Lung Dis       Date:  2007-10       Impact factor: 2.373

Review 9.  Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis.

Authors:  Hsien-Ho Lin; Majid Ezzati; Megan Murray
Journal:  PLoS Med       Date:  2007-01       Impact factor: 11.069

10.  Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults.

Authors:  David W Dowdy; Maria C Lourenço; Solange C Cavalcante; Valeria Saraceni; Bonnie King; Jonathan E Golub; David Bishai; Betina Durovni; Richard E Chaisson; Susan E Dorman
Journal:  PLoS One       Date:  2008-12-29       Impact factor: 3.240

View more
  34 in total

1.  Mycobacterium bovis BCG-mediated protection against W-Beijing strains of Mycobacterium tuberculosis is diminished concomitant with the emergence of regulatory T cells.

Authors:  Diane J Ordway; Shaobin Shang; Marcela Henao-Tamayo; Andres Obregon-Henao; Laura Nold; Megan Caraway; Crystal A Shanley; Randall J Basaraba; Colleen G Duncan; Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2011-07-27

2.  Population dynamics of tuberculous Bacilli in Cameroon as assessed by spoligotyping.

Authors:  Francioli Koro Koro; Yannick Kamdem Simo; Félix Fotso Piam; Jurgen Noeske; Cristina Gutierrez; Christopher Kuaban; Sara Irène Eyangoh
Journal:  J Clin Microbiol       Date:  2012-10-31       Impact factor: 5.948

Review 3.  Tuberculosis and HIV co-infection: screening and treatment strategies.

Authors:  Kartik K Venkatesh; Soumya Swaminathan; Jason R Andrews; Kenneth H Mayer
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

4.  Pyrido[1,2-a]benzimidazole-based agents active against tuberculosis (TB), multidrug-resistant (MDR) TB and extensively drug-resistant (XDR) TB.

Authors:  Marco Pieroni; Suresh K Tipparaju; Shichun Lun; Yang Song; A Willem Sturm; William R Bishai; Alan P Kozikowski
Journal:  ChemMedChem       Date:  2011-01-21       Impact factor: 3.466

5.  The Mycobacterium tuberculosis early secreted antigenic target of 6 kDa inhibits T cell interferon-γ production through the p38 mitogen-activated protein kinase pathway.

Authors:  Hui Peng; Xisheng Wang; Peter F Barnes; Hua Tang; James C Townsend; Buka Samten
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

6.  Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosis.

Authors:  Crystal A Shanley; Gregory C Ireton; Susan L Baldwin; Rhea N Coler; Steven G Reed; Randall J Basaraba; Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2013-09-07       Impact factor: 3.131

Review 7.  The microbiome at the pulmonary alveolar niche and its role in Mycobacterium tuberculosis infection.

Authors:  Alexander J Adami; Jorge L Cervantes
Journal:  Tuberculosis (Edinb)       Date:  2015-07-30       Impact factor: 3.131

8.  Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014-2018.

Authors:  Gloria Bahizi; Robert Kaos Majwala; Stevens Kisaka; Abdunoor Nyombi; Kenneth Musisi; Benon Kwesiga; Lilian Bulage; Alex Riolexus Ario; Stavia Turyahabwe
Journal:  Antimicrob Resist Infect Control       Date:  2021-05-08       Impact factor: 4.887

9.  Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection.

Authors:  Max R O'Donnell; Nesri Padayatchi; Charlotte Kvasnovsky; Lise Werner; Iqbal Master; C Robert Horsburgh
Journal:  Emerg Infect Dis       Date:  2013-03       Impact factor: 6.883

10.  Tuberculosis Infection: Occurrence and Risk Factors in Presumptive Tuberculosis Patients of the Serengeti Ecosystem in Tanzania.

Authors:  Erasto V Mbugi; Bugwesa Z Katale; Athumani M Lupindu; Julius D Keyyu; Sharon L Kendall; Hazel M Dockrell; Anita L Michel; Mecky I Matee; Paul D van Helden
Journal:  East Afr Health Res J       Date:  2017-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.